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What other treasures 
could be hidden in 
conference papers? 
SIR — In the obituary of Anatol 
Zhabotinsky (Nature 455, 
1053; 2008), Irving Epstein 
mentions Boris Belousov, with 
whom Zhabotinsky shared the 
Lenin Prize in 1980 for their 
contributions to the Belousov–
Zhabotinsky oscillatory chemical 
reaction system. 
Epstein says “Belousov tried 
to publish his results in peer-
reviewed journals, but eventually 
gave up after referees and editors 
insisted that such behaviour 
contradicted the Second Law of 
Thermodynamics. He instead 
published a one-page description 
of his observations in an obscure 
conference proceedings on 
radiation medicine.” That 
paper1, ‘A periodic reaction and 
its mechanism’, gained little 
attention at the time. 
Papers published in symposium 
proceedings do not usually 
merit citation, because they 
are not peer-reviewed. They 
receive little recognition. Very 
few are even indexed in the main 
journal databases — one notable 
exception being PubMed’s listing 
of the annual Cold Spring Harbor 
Symposium on Quantitative 
Biology.
However, other ‘hidden’ 
conference papers have also 
subsequently provoked acclaim. 
The pioneering work of physicist 
Abdus Salam and chemist Koichi 
Tanaka aroused little interest 
when it was first published in this 
way2,3. Fortunately, these findings 
were later recognized for their 
originality and importance: 
Salam went on to win the 1979 
Nobel Prize in Physics, and Tanaka 
was awarded the 2002 Nobel 
Prize in Chemistry.
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Public opinion and 
the ethics of primate 
brain research
SIR — Several issues in your 
News story ‘German authority 
halts primate work’ (Nature 455, 
1159; 2008) call for clarification. 
Freedom of research is written 
into German basic law, but so is 
animal protection. This reflects 
concerns in society at large about 
the ethics of subjecting animals 
to pain and distress in research, 
as well as in farming and for 
entertainment. Even a prominent 
scientist such as Andreas Kreiter 
must justify his use of animals.
Although Kreiter refers to the 
ethical judgement by Bremen’s 
senate of health as “purely 
arbitrary”, it is backed by a 
political majority in the Bremen 
Senate as well as by the majority 
of Bremen’s citizens, as confirmed 
in petitions and opinion polls.
You say that “the ruling 
ignores a positive judgement 
rendered last year by an expert 
commission comprising scientists 
and representatives of animal-
welfare organizations”. But the 
commission restricted itself to 
assessing the scientific merits of 
Kreiter’s research, not the ethical 
issues — thereby failing in part 
of its mandate, which expressly 
included ethical issues. 
Also, there was only a single 
animal-welfare specialist 
among the five members of this 
commission; the remainder 
were scientists who conduct 
brain research in primates or 
breed them for research. The 
previous year, one of them had 
himself been denied permission, 
on ethical grounds, to conduct 
invasive brain research. Moreover, 
you imply that the animal-welfare 
specialist also approved the 
monkey experiments. Nothing 
could be further from the truth.
This is not the first time that the 
expert group’s judgement has been 
misrepresented to the media by 
scientists and university officials. 
Again and again the German 
Animal Welfare Federation has 
been forced to try and correct the 
mistaken impression that experts 
in science, ethics and animal 
welfare unanimously endorsed 
Kreiter’s project. 
Kreiter’s failure to explain 
satisfactorily to the public exactly 
what he is doing is seriously 
undermining his credibility, 
and that of scientists in general. 
Insisting that the ethical concerns 
are unreasonable and that the 
constitutional mandate of animal 
protection is an undemocratic 
assault on academic liberty 
deepens the antagonism between 
town and gown. 
You quote Stefan Treue as saying 
he “just can’t see why what’s 
perfectly fine in one place should 
be unethical in another”. In fact, 
monkey-brain research much like 
Kreiter’s in the level of suffering 
it causes has been prohibited in 
Munich, Berlin and Zurich.
Kreiter’s centre for primate 
research in its present form is now 
in jeopardy. He should face the 
fact that ethical standards have 
evolved since he started this work 
and that he has lost touch with the 
majority of his fellow citizens.
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Marker metabolites 
can be therapeutic 
targets as well
SIR — Your News & Views 
Q&A article ‘Systems biology: 
metabonomics’ (Nature 455, 
1054–1056; 2008) highlights the 
importance of metabonomics in 
the identification of metabolites 
associated with disease — 
for example, as biological 
markers for disease state and 
susceptibility, and for monitoring 
response to treatment. However, 
metabonomics can also be useful 
for determining the therapeutic 
potential of metabolites whose 
levels are altered in a particular 
disease state. 
If changing concentrations of a 
specific metabolite can be linked 
to the genesis or progression of 
a disease, then there may be a 
therapeutic advantage in restoring 
these to normal values. This 
strategy has been successful, 
or at least promising, in many 
cases. For example, several 
anticancer treatments exploit 
the antiproliferative action of 
ceramide, the concentration of 
which decreases in certain cancer 
types (C. P. Reynolds et al. Cancer 
Lett. 206, 169–180; 2004). Also, 
increasing the concentrations 
of S-nitrosothiol metabolites in 
the airway-lining fluid, which are 
lowered in patients with asthma, 
seems to have a protective effect 
in animal models (L. G. Que et al. 
Science 308, 1618–1621; 2005).
Metabolites have a variety 
of cellular functions, including 
acting as direct regulators of gene 
expression, so it is not surprising 
that they can also function as 
effectors of molecular events 
that contribute to disease. Those 
positively associated with disease 
causation may be rarer than those 
that simply result from a disease. 
The human metabolome 
comprises thousands of 
endogenous molecules, many of 
whose functions are unknown. 
We believe that the concept of 
disease-associated metabolites 
as potential therapeutic agents 
is underexploited, in comparison 
with their widespread use as 
biological markers.
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